Aryastha Life Sciences raises funding from Vessella Group
Hyderabad-based Aryastha Life Sciences, a Contract Research and Development Organization, has concluded its Series A funding with significant backing from Vessella Group. Aryastha offers preclinical models derived from patient samples and pluripotent stem cells for efficient drug screening.
Want to receive such news items in your inbox? Click Here to sign up for a trial.